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Abstract
Background: Alternative splicing, which produces multiple mRNAs from a single gene, occurs in most human genes and
contributes to protein diversity. Many alternative isoforms are expressed in a spatio-temporal manner, and function in
diverse processes, including in the neural system.
Methodology/Principal Findings: The purpose of the present study was to comprehensively investigate neural-splicing
using P19 cells. GeneChip Exon Array analysis was performed using total RNAs purified from cells during neuronal cell
differentiation. To efficiently and readily extract the alternative exon candidates, 9 filtering conditions were prepared,
yielding 262 candidate exons (236 genes). Semiquantitative RT-PCR results in 30 randomly selected candidates suggested
that 87% of the candidates were differentially alternatively spliced in neuronal cells compared to undifferentiated cells.
Gene ontology and pathway analyses suggested that many of the candidate genes were associated with neural events.
Together with 66 genes whose functions in neural cells or organs were reported previously, 47 candidate genes were found
to be linked to 189 events in the gene-level profile of neural differentiation. By text-mining for the alternative isoform,
distinct functions of the isoforms of 9 candidate genes indicated by the result of Exon Array were confirmed.
Conclusions/Significance: Alternative exons were successfully extracted. Results from the informatics analyses suggested
that neural events were primarily governed by genes whose expression was increased and whose transcripts were
differentially alternatively spliced in the neuronal cells. In addition to known functions in neural cells or organs, the
uninvestigated alternative splicing events of 11 genes among 47 candidate genes suggested that cell cycle events are also
potentially important. These genes may help researchers to differentiate the roles of alternative splicing in cell
differentiation and cell proliferation.
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Introduction
The number of human genes (approximately 23,000 accordingto
the Human Genome Project [1]) is just slightly higher than the
number in lower eukaryotes such as worms. Most human exons are
constitutive. However, .90% of human genes undergo in
alternative splicing [2], a much higher percentage than that in
lower eukaryotes [3]. Alternative splicing changes the use of exons,
producing multiple types of transcripts from a single gene. Each
transcript is translated into unique protein isoform. Alternative
splicing enhances proteomic diversity to support complexity in
higher eukaryotes [4]. Many alternative isoforms have distinct or
opposing functions modified from another isoform, and play
important biological roles [5,6]. Alternative splicings often occur
in a spatiotemporal manner, and some are regulated by alternative
splicing regulators. In the case of neural tissues, several regulators,
such as nPTB, Nova1, Fox-1, and their target pre-mRNAs have
been identified [7–9]. Understanding alternative splicing networks
is very important, because splicing is one of important gene
expression processes and affected on gene expression network [10].
There are five basic types of alternative splicing that involve
only the differential use of splice sites: exon skipping, 59 or 39 splice
site (ss) selection, mutually exclusive, and retained intron [4]. In
addition, 39ss selection and/or the selection of poly-A additional
signals help regulate alternative termination. Alternative promot-
ers promote the differential use of the first exons adjacent to the
transcriptional initiation sites, a process that is sometimes
considered as an alternative splicing event [5,11]. Alternative
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The differential use of exon, generated by alternative splicing
events, including alternative termination and alternative promot-
ers, generally changes some of amino acid codes of the expressed
protein.
Several technologies, such as microarrays and high-throughput
sequencing, have been developed to analyze alternative splicing in
genome-wide scale [reviewed in [12]]. Junction and exon arrays
are the two main microarrays to investigate alternative splicing
employing probes specific to the exon(s). Exon array probes are
designed for each exon, while probes of junction arrays are
designed for exon-exon junctions. The GeneChip Exon Array
produced by Affymetrix is a convenient assay in which operations
from sample preparation to scanning are performed in a standard
gene expression profiling environment [13]. Although various
studies using Exon Array have been published, few have efficiently
extracted alternative splicings from Exon Array results and
validated by RT-PCR [14–19]. Even fewer reports have applied
and analyzed the validated potential alternative exons using gene
ontology (GO) or pathway analyses [18,19].
P19 mouse embryonic carcinoma cells are a multi-potent cell
type that can differentiate into either neural or cardio muscular cells
depending on the retinoic acid (RA) concentration in the medium
[20,21]. We previously reported the regulation of neural-specific
splicing of the Mef2c exon b in P19 cells [22]. The transcription
factor Mef2 plays important roles in muscle differentiation and
synaptogenesis [23,24]. Fox-1 promoted the inclusion of Mef2c
exon b via the GCAUG sequence [22]. In addition to Mef2c exon b
and Fox-1, many alternative splicing events likely occur in a neural-
specific manner during the neuronal differentiation of P19 cells.
These splicing events are presumably regulated by splicing-
regulators that are also expressed in a neural-specific manner.
The alternatively spliced products, such as transcription factors,
affect the transcriptional networks and function in neural events.
The goal of the present study was to comprehensively
investigate neural-splicing using P19 cells. A GeneChip Exon
Array was performed using total RNAs purified from undifferen-
tiated P19 cells (Day 0), neuronal differentiated cells (Day 7), and
cells from the early glial stage (Day 10). Nine filtering conditions
were used for probe sets based on their annotations, estimated
gene expression levels, splicing index (SI), detection above back
ground (DABG) values, and predictions of alternative splicing. A
total of 262 differentially alternatively spliced (DAS) candidate
exons of neural splicing were extracted. Thirty exons among the
262 DAS exons were validated by RT-PCR. The RT-PCR
experiments suggested that 87% of these exons were actually
changed between undifferentiated and neuronal differentiated
cells. This result indicated the method of the candidate exons
extraction was very successful. Results from informatics approach-
es, including GO analysis, text-mining, and pathway analysis, also
suggested that many of the candidate exons were related to neural
events. In addition to gene-level informatics analyses, text-mining
for the alternative isoform were performed. This informatics
analysis is a new trial to identify exon-level annotations.
Methods
Cell culture and RNA purification
P19 cells were maintained in Minimum Essential Medium
(MEM) a Medium (a-MEM; Sigma) supplemented with 10% fetal
bovine serum (FBS; Sigma) [25]. To induce neuronal cell
differentiation, P19 cells (1610
5 cells/mL) were treated with
1 mM all trans-retinoic acid (RA) for 4 d in a 10-cm petri dish
(Falcon) with a-MEM containing 10% FBS as described
previously [22,25]. Total RNAs were collected from undifferen-
tiated cells (Day 0), cells during neuronal differentiation (Day 1, 4,
7), and from cells in the early glial stage (Day 10) using RNeasy
(Qiagen).
Exon array
Both cDNA and cRNA syntheses were performed as described
in the supplier’s instructions. Total RNAs from undifferentiated
(Day 0), neuronally differentiated P19 (Day 7), and early glial stage
cells (Day 10) were applied to a GeneChip Mouse Exon 1.0 ST
Array (Affimetrix). Hybridization, washing and scanning were
performed on a fluidics station and a GeneChip scanner
(Affimetrix) according to the supplier’s instructions. The accession
number of the Exon Array data is GSE23710.
Estimation of signals
Signal data of the CEL files were sketched, normalized, and
summarized with the PLIER method for exon-level intensities and
with the Iter-PLIER for gene-level intensities using the Affymetrix
Expression Console. The ‘‘core’’ option was used in both cases,
which limits analysis to RefSeq-mapped probesets and to the
mRNA of full-length CDS. The presence or absence of each probe
was determined by the DABG p-values. Signal estimates of 3 time
points (Day 0, 7, and 10) with biological duplicates were
summarized with various annotations supplied by Affymetrix,
such as probeset positions, transcript accessions, and probe
sequences.
Extraction of the candidate exons and genes
Although multiple probesets are designed within the same exon,
probeset intensities represent the expression levels of exons. The
ratio of the probeset intensity to the gene intensity, designated as
the normalized intensity (NI), was estimated in 3 time points (NId0,
NId7, and NId10). The splicing index (SI) was calculated by taking
the log ratio (base 2) of the averaged NIs of biological duplicates
[19,26]. Probesets annotated as having a high potential of cross-
hybridization were removed from the analysis. The
SId7~log AvgNId7=AvgNId0 ðÞ , SId10~log AvgNId10=AvgNId0 ðÞ
splicing patterns of exons were predicted from using the UCSC
Blast-like alignment (blat) search tool (http://genome.ucsc.edu/
cgi-bin/hgBlat). An automatic system of alternative splicing
prediction was created using the UCSC blat and NCBI BLAST
(Basic Local Alignment Tool) searches. A detailed explanation of
the candidate exon extraction process is described in the Results
section (see also Table 1).
A gene was defined as ‘‘expressed’’ when $50% of probesets of
the same gene had a DABG p-value of #0.05 in both biological
duplicate of the same time point [19,26]. Genes that were defined
as ‘‘expressed’’ on both Day 0 and 7 or on either Day 0 or 7 were
analyzed. For gene-level expression analysis, these ‘‘expressed’’
genes were categorized as differentially expressed upregulated
(DEX-up) or downregulated (DEX-down). A gene was categorized
in the DEX-up group if its expression level increased $2-fold and
#10-fold from Day 0 to Day 7, and decreased from Day 7 to Day
10. A gene was categorized in the DEX-down group if its
expression decreased $2-fold and #10-fold from Day 0 to Day 7,
and increased from Day 7 to Day 10.
Semiquantitative RT-PCR
The total RNAs of P19 cells were prepared as described above.
Total RNAs from mouse tissues were obtained from a commercial
Exon Array Analysis of AS in P19 Neuronal Cells
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using SuperScript III (Invitrogen) and 0.5 mg of oligo dT primer in
20-mL reaction mixture. The cDNAs are used as templates for the
PCR. The PCRs were performed using the GoTaq polymerase
(Promega) with specific primers. The DNA primer sequences,
number of cycles, and annealing temperatures for the candidates
are described in Table S1. Those for b-Actin and GluR1 were
described in a previous report [22]. The PCR products were
analyzed on a 6% polyacrylamide gel. The gels were stained with
SYBR Green I (Takara), and the images were analyzed in LAS-
3000 (Fuji Film). The sequences of the PCR products are
confirmed in the 3100 DNA sequencer (ABI). Accession numbers
of sequences for novel alternative variants are shown in Table 2.
Densitometry was performed using MultiGauge v 3.0 software
(Fuji Film). Each experiment was performed $3 times to confirm
reproducibility.
Gene ontology analysis, pathway analysis and text-
mining
The GO analyses were performed for genes with candidate
exons and for genes in the DEX-up and DEX-down groups [27].
Statistically-significant biological process terms were obtained with
Fisher’s Exact Test (p#0.01) using PathwayStudioH (Ariadne
Genomics, Inc, Rockville, MD, USA) [27,28].
Results
Extraction of the alternative exon candidates
Because probes of ‘‘core’’ exons was used, most of the analyzed
probes were constitutive exons. Nine filtering conditions were
constructed to extract the candidate exons of alternative splicings
(Table 1). The filtering procedures (including our original
procedures) were arranged by considering the general features of
alternative splicing and previous concepts of exon extraction [26].
Because many outermost probesets are designed at potential exons
outside of the genes, the first and last probesets of each gene were
removed. Since the length of most human exons is ,300
nucleotides (nt) [29], probesets with sequence of .500 nt were
excluded. The long probesets mostly indicate untranslated region
(UTR). Probesets with an annotation of a high potential for cross-
hybridization were also removed. After filtering with these
conditions, 221,336 probesets of core exons of 16,661 genes were
reduced to 159,552 probesets of 15,238 genes (Table 1, third
procedure).
To identify alternative splicings, genes should be expressed on
both Day 0 and Day 7. The reliability of gene expression level was
determined by the DABG p-values of the probesets (see Methods)
[19,26]. Probesets of genes expressed on both Day 0 and Day 7
were retained on the list (Table 1, fourth procedure). In addition,
exon expression level should be detected at Day 0 or Day 7.
Probesets with in a DABG p-values of #0.05 on Day 0 or 7 were
accepted for the next filtering procedure. These filtering conditions
reduced the number of probesets to 94,780 (Table 1, fifth
procedure).
The splicing index SI of a probeset represents its change in exon
expression, which is adjusted according to its gene-level expres-
sion. The A-value is the average intensity between Day 0 and 7.
SId7 values and A-values of 94,780 probesets are plotted in
Figure 1A. Most probesets were closely plotted in the middle
(SId7=0.00). This result indicated that probesets with a small
absolute value of SId7 (ABS_SId7) were not related to the
alternations in exon usage between Day 0 and 7. A threshold
61.35 of SId7 (2.55-fold) was set, and probesets with $1.35
ABS_SId7 were retained on the list (Table 1, sixth procedure).
SI of probeset represents a change of exon expression, which is
adjusted with its entire gene level expression. However, Because
the SI of a probeset cannot indicate the relationship between
adjacent exons, the difference in SId7 values was assessed in a local
area of the transcript. We separately extracted the adjacent
downstream or upstream probesets that were surely expressed (no
cross-hybridization, DABG p-value #0.05). When $1 of the
adjacent probesets had an ABS_SId7 value of #0.667, the
probesets were retained on the list (Table 1, seventh procedure).
Theoretically the probeset indicates a border between alternative
and constitutive exons after this filtering condition. If a probeset
Table 1. Procedures applied to extract alternative exon candidates.
Exons* Genes
Filtering Conditions # of Probesets and Gene Probesets
Estimated signals using CoreGene and CoreExon by Expression Console 221,336 16,661
1. Remove probesets that have Max. or Min. number of ‘probeset ID start’ in each gene 188,374 15,753
2. Remove probesets that indicate possible UTRs (Length of probeset ID sequence ,500 nt) 185,028 15,654
3. Remove probesets that cause non-specific adsorption (x-hybr; FALSE) 159,552 15,238
4. Keep the genes expressed on both Day 0 and Day 7 102,661 8,601
5. Keep the exons expressed on either Day 0 or Day 7 or both (p#0.05 in DABG) 94,780
1 8,541
6. Keep probesets that significantly change their expression between Day 0 and Day 7 (ABS_SId7 $1.35) 1,636 948
7. Remove a probeset if both of its neighbors change expression 1,107 805
8. Keep probesets that indicate possible alternative exons in database (ucsc blat search) 309 278
9. Keep a probeset that its ABS_SId7 value is larger than its ABS_SId10 value 262 236
* The probeset likely indicate an exon, although multiple probesets may exist in an exon.
1 Signals of these probesets were plotted using the SId7 value (Figure 1). Note: In the fourth procedure, genes were retained if $50% of probesets in each gene had
p#0.05 in DABG. In the seventh procedure, according to the of probeset ID start position, upstream and downstream neighbor probesets were searched whose
expression was detectable (DABG; p#0.05). If ABS_ SId7 value of the neighboring probeset was $0.667, the neighbor was considered to have changed expression. A
probeset was removed if both of its neighbors changed expression. If a probeset with only one neighbor, the probeset was removed if that neighbor changed
expression. In the ninth procedure, in addition to comparing of the ABS_SI values, a probeset was retained when its SId7 and SId10 were a negative number and $1.35,
respectively, or when its SId7 and SId10 are a positive number and #21.35, respectively.
doi:10.1371/journal.pone.0016880.t001
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value of #0.667, then complex splicing events would be
accidentally removed.
Since most the probesets were designed to constitutive exons, it
is possible that many constitutive exons are involved in the 1,107
exons that were left after the seventh filtering (Table 1). We
searched these probesets’ sequences in the UCSC blat and found
alternative exons. The probeset was categorized as a candidate
alternative exon. When a probeset sequence resulted in multiple
hits for mRNA fragments in Genbank and EST and also skipped
other multiple fragments in the range of each gene on genomic
structure, then the probeset was categorized as an alternative
exon. An automatic system was used to a double check these
sequences. Contradictory exons were manually curated in the
UCSC blat search again. Approximately 28% of the probesets
(309 probesets) were predicted to be alternative exons (Figure 1B &
Table 1, eighth procedure).
Finally, the SId7 and SId10 values were compared. A probeset
was retained if its SId7 was larger than SId10 when SId7 was
positive (or smaller than its SId10 value when SId7 was negative)
(Table 1, ninth procedure). Altogether, 262 probesets containing
all alternative splicing types were extracted (Table S2 & Figure 1C).
These probesets were identified as DAS exons that potentially had
undergone alternative splicing in a neural-specific manner.
Semiquantitative RT-PCR for the candidate exons
To examine whether the potential DAS exons are actually
involved in alternative splicing during the neuronal differentiation
of P19 cells, semiquantitative RT-PCR was performed. Semi-
quantitative RT-PCR is more appropriate than qPCR in the
analysis of alternatively spliced products. Among 262 DAS exons,
30 exons were randomly selected (Figure 2A & Figure S1A).
Typical patterns for the DAS events in P19 cells are shown in
Figure 2B. Densitometric analysis showed alternative splicing of 10
Table 2. Validation of alternative splicings in neuronal differentiation as detected by RT-PCR.
Gene Probeset ID SId7 Exon type Neural AS Change of PCR product (%/%) Length (nt) Novel splicing
Abi2 4987109 1.67 Exon skip + 7.44 Hold d7/d0 of 329nt 329, 146 -
Aff3 5291502 3.81 Exon skip ++ 53.87 Hold d7/d0 of 178nt 178, 102 -
Ank3 5060679 23.30 39sss + 4.78 Hold d0/d7 of 703nt 703, 115 -
Aplp2 5477899 2.04 Exon skip + 5.88 Hold d7/d0 of 197nt 197, 157 -
Arhgef12 5209805 21.44 Alt terminater - 1.90 Hold d0/d7 of 111nt 166, 111 -
Atf2 5194737 1.85 Exon skip + 5.45 Hold d7/d0 of 335nt 335, 272, 195, 132 AB575970
Atp1a3 5385869 22.71 Retained intron ++ 16.88 Hold d0/d7 of 446nt 446, 109 -
Bai2 5286600 22.05 Exon skip, Mutual + 5.20 Hold d7/d0 of 173nt 209, 173, 110 -
Bcl11a 4969426 21.43 59sss, Alt terminater + 2.82 Hold d7/d0 of 153nt 201, 153, 101 -
Clta 4399984 3.05 Exon skip, Mutual + 5.93 Hold d7/d0 of 204nt 204, 168, 150, 114 AB575971
Dlg3 5344442 5.39 Exon skip, Mutual ++ 52.04 Hold d7/d0 of 198nt 252, 198, 156, 152 AB575972
Epb4.1l3 5517310 2.76 Exon skip + 5.78 Hold d7/d0 of 264nt 339, 264, 141 -
Epb4.1l3 4866829 2.04 Exon skip + 2.54 Hold d7/d0 of 224nt 224, 127 -
Fam113a 4648309 22.98 Exon skip, 39sss + 3.74 Hold d7/d0 of 102nt 363, 182, 102 AB575973
Fchsd2 4408143 3.36 Exon skip ++ 19.52 Hold d7/d0 of 235nt 235, 163 -
Gnao1 4489479 21.62 39sss, Alt terminater + 2.12 Hold d0/d7 of 189nt 189, 124 -
Kif1b 4352234 2.15 Exon skip + 5.70 Hold d7/d0 of 193nt 235, 193, 157, 115 AB575974
Kif21b 5130589 2.85 Exon skip ++ 111.60 Hold d7/d0 of 311nt 311, 131 -
Kif2a 5345537 4.23 Exon skip ++ 135.44 Hold d7/d0 of 231nt 231, 117 -
Neo1 5491604 1.77 39sss + 6.84 Hold d7/d0 of 153nt 153, 105 -
Neo1 4604088 5.90 Exon skip ++ 31.00 Hold d7/d0 of 151nt 151, 118 -
Plekha5 5343636 1.59 Exon skip, 59sss, 39sss ++ 17.93 Hold d7/d0 of 346nt 346, 230, 154 AB575975
4740762 2.06
Rbm9 5479607 2.04 Alt promoter + 7.41 Hold d0/d7 of 251nt 251, 157, 134 -
Rnf138 4323558 2.31 Exon skip - 1.17 Hold d7/d0 of 317nt 317, 209 -
Rufy3 4321833 21.85 Exon skip, Alt promoter + 2.01 Hold d0/d7 of 157nt 157, 103 -
Snap91 4960676 2.78 Exon skip ++ 14.98 Hold d0/d7 of 162nt 246, 162 -
Tmem219 5381697 21.91 Alt promoter, Exon skip, 39sss - 1.58 Hold d0/d7 of 293nt 263, 94 -
Tpd52l2 4473030 1.86 Exon skip ++ 12.47 Hold d7/d0 of 185nt 185, 158, 116 -
Tprkb 5267179 22.75 Exon skip - 1.00 Hold d7/d0 of 104nt 188, 104 -
Zfp326 5023736 2.31 Exon skip, 59sss, 39sss, + 2.94 Hold d0/d7 of 123nt 529, 426, 265, AB575976-
Retained intron 240, 123 AB575978
Percentages of the relative amounts of alternative exons were compared between Day 7 (D7) and Day 0 (D0). (2) Changes is ,2-fold, or the change on Day 10 is larger
than Day 7, (+) Change is .2-fold but ,10-fold, and (++)Change is .10-fold. sss, Splice site selection.
doi:10.1371/journal.pone.0016880.t002
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cells) and Day 7 (differentiated P19 cells). The changes in the
alternative splicing of the other 16 exons were .2-fold but ,10-
fold (Table 2 & Figure S2B). The expressions of these 26 exons
increased or decreased consistent with the directions indicated by
SI d7. The changes of these 26 exons on Day 7 were greater than
those on Day 10, consistent with the results in Table 1 (ninth
procedure). These results show that neuronal cell stage-specific
alternative splicing occurred in these 26 of 30 exons, and suggested
that 87% of the 262 DAS exons were involved in neural splicing.
Seven alternative splicing events had novel splicing patterns
(Kif1b, Dlg3, Plekha5, Atf2, Clta, Fam113a, and Zfp326; Table 2) in
mouse. The patterns included a novel exon, novel splice sites, and
novel combinations. Except for the novel Dlg3 variant, the other 6
variants were detected in adult mouse brain (Figure S2C). Among
26 alternative exons, the percentages of alternative variants of 17
exons were changed .2-fold in the brain compared to other
tissues, which showed expression patterns similar to those in the
brain (Figure 2C & Figure S1C). Although the differentiation of
P19 cells is a model system, this result implied that alternative
splicings of more than half of DAS exons had similar regulations
between neuronal differentiated P19 cells and brain.
Gene ontology analysis of the candidate exons
To test whether the 262 DAS exons of 236 DAS genes were
involved in neural events, GO analysis was performed using the
Biological Process category. A total of 72 GO terms (p#0.01,
Fisher’s Exact test) were obtained from the 236 DAS genes. These
terms were classified into 10 groups: neural-related process (there
were no neural-related terms in other terms), differentiation and
development, cytoskeleton and cell adhesion, signaling, post-
Figure 1. Statistical analyses of the extraction of candidate
exons. (A) SI-A plot for 94,780 probesets after the fifth procedure in
Table 1. Vertical and horizontal axes show SId7 values and A-values,
respectively. (B) Percentage of the predicted alternative exon. The 2,650
probeset ID sequences whose ABS_SId7 values were .1.0 (see also sixth
procedure of Table 1) were assessed for whether they indicated the
alternative exon. Dots indicate percentages of the alternative exon in
each group of 50 probesets from the highest ABS_SId7 to approximately
1.0. Dotted line indicates the approximation curve. Vertical broken line
indicates the threshold (ABS_SId7=1.35) in Table 1. Horizontal broken
line (27.9%) indicates the percentage of the predicted alternative exon.
(C) Percentage of alternative splicing types in the DAS exons. The types
of alternative splicings of 262 probeset ID sequences were searched
using UCSC blat search.
doi:10.1371/journal.pone.0016880.g001
Figure 2. Semiquantitative RT-PCR experiments. (A) Schematic
representations of alternative splicing. Thirty exons were randomly
selected from 262 DAS exons. Five of 30 exons (Neo1 exon17, Kif21b,
Plekha5, Dlg3, and Kif1b) are shown; the other exons are shown in
Figure S1. Boxes and middle lines indicate exons and introns,
respectively. Gray indicates possible alternative exon. Arrows indicate
the locations of primer annealing sites. Numbers indicate the length of
PCR products. The sequences of PCR products were confirmed by
sequencing analysis. Semiquantitative RT-PCR in P19 cells (Day 0, 1, 4, 7,
and 10) (B) and in adult mouse brain and other tissues (C). b-Actin was
used as a control. GluR1 was used as a neural differentiation marker (B
only). Schematic representations of the PCR products are shown on the
right side of the panels.
doi:10.1371/journal.pone.0016880.g002
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cellular transport, apoptosis, and others. The neural-related
process group was the most abundant, accounted for 20.8% of
all terms, followed by differentiation and development (12.5%),
cytoskeleton and cell adhesion (12.5%), and signaling (9.7%)
(Figure 3A).
The 262 DAS exons were categorized into two groups
according to whether the SId7 value was $+1.35 (DAS-up; 153
genes) or #21.35 (DAS-down; 88 genes). The percentage of
neural-related GO terms in the DAS-up and DAS-down groups
were 17.0% and 21.2%, respectively (Figure 3B). This result
suggests that the protein isoforms translated from these alterna-
tively spliced transcripts, which were either included or excluded
exons, were involved in neural events.
Affymetrix Expression Console calculates the expression level of
each gene based on the intensities of probesets of the Exon Array.
We analyzed the gene expression of the same samples and
obtained the differentially expressed (DEX) genes in P19 neuronal
cells. The expression of 1666 DEX-up genes increased $2-fold
and #10-fold from Day 0 to Day 7, and decreased from Day 7 to
Day 10 (Table S3). The DEX-up gene group had 194 GO terms,
including neural-related process (20.1%) and differentiation and
development terms (18.6%) (Figure 3B). The DEX-up and DAS
gene results were quite similar, suggesting that genes in both
groups were related with neural-events (Figure 3C).
A total of 550 DEX-down genes were obtained, whose
expression levels decreased $2-fold and #10-fold from Day 0 to
Day 7 and increased from Day 7 to Day 10 (Table S4). The DEX-
down genes had 107 cell process GO terms. The percentage of
neural-related processes in all 107 terms was only 2.8%, and those
of cellular transport and apoptosis were 11.0% and 5.6%
(Figure 3B). The GO terms of DEX-down genes showed unique
patterns compared with those of the DAS, DAS-up, DAS-down,
or DEX-up genes, suggesting that the DEX-down genes are not
responsible for neural-events (Figure 3C).
Potentially important exons extracted by pathway
analysis and text-mining
Text-mining and pathway analysis were performed for the DAS
genes using MedScanH text-mining technology in PathwayStudioH
(Ariadne Genomics) [28]. Of the 236 DAS genes, the functions
(cell process) 151 genes have been reported in multiple
publications. The remaining 85 genes were categorized as
‘unknown genes’. Of the151 DAS genes with known functions,
66 were categorized as ‘well-known genes’ in neural processes
since their functions in neural cells or organs were reported
previously. The remaining 85 were categorized as ‘functional DAS
genes’, having little reported evidence of neural regulatory roles
(Figure 4A & 4C). This suggests that many DAS genes are related
with neural events, as already shown by GO analyses. Because 66
well-known genes has been studied in neural cells or organs,
further research about functional differences between alternative
isoforms will probably clarify their functions in non-neural cells or
organs. It will be very difficult to analyze alternative isoforms in
the 85 unknown genes, since there are too few clues about their
functions. Therefore, we focused on the 85 functional DAS genes.
In order to extract potentially important genes from the 85
functional DAS genes, we focused on DEX-up genes since DEX-
up genes and DAS genes might affect on their expressions each
other. As shown in GO analysis (Figure 3), in contrast to the DEX-
down genes, many of the DEX-up genes seemed to regulate neural
events. A total of 279 cell process terms closely related to DEX-up
genes were extracted from the literature using text-mining and
PathwayStudioH database (Figure 4B). Ninety overlapping terms
of DEX-up and DEX-down groups were subtracted from the 279
terms. The remaining 189 cell process terms are presumed to be
responsible for events in the neuronal P19 cells.
We next extracted biological relationships between the 189 cell
processes and 85 functional DAS genes. Forty-seven DAS genes
were linked to these cell processes (Figure 4A & Table S5). These
47 genes are potentially important, because isoforms created by
neural splicing may acquire novel functions that have not been
reported in neural cells. Eleven genes out of the 47 genes were
involved in cell cycle-related events, processes in the G1 and/or S
phase (Figure 5). This result is reasonable, since cell proliferation
and cell differentiation are very closely related.
Informatics and experimental analyses of splicing
isoforms
In addition to the above gene-level analyses, we tried to perform
exon-level informatics analyses. Among 236 DAS genes, 49 genes
Figure 3. Gene Ontology analysis. (A) GO analysis in 262 DAS exons
(236 DAS genes). Seventy-two GO terms (p-value #0.01; Fisher’s t-test)
were found from the 236 DAS genes. These terms were categorized into
10 groups. The percentage of the GO terms is shown. (B) The GO
analysis at the DAS and DEX genes. The 236 DAS genes were divided
into DAS-up (153 genes) and DAS-down (88 genes) groups, according
to whether the exon expression levels were elevated or reduced,
respectively, on Day 7 compared to Day 0. DAS-up and DAS-down
groups were examined in GO analysis. The gene expressions of 1,666
DEX-up genes were elevated (from 2- to 10-fold) on Day 7 compared
with Day 0, and decreased from Day 7 to Day 10. The gene expressions
of 550 DEX-down genes were reduced (from 2- to 10-hold) on Day 7
compared with Day 0, and increased from Day 7 to Day 10. DEX-up and
DEX-down genes were separately analyzed in GO analysis. (C) Primary
relationship between expression profile and GO terms. The DEX-down
genes showed markedly fewer neural-related GO terms. The DEX-up
and DAS genes are primarily responsible for the neural-related GO
terms, and seem to be equivalent to other events occurring in the
neuronal differentiation in P19 cells.
doi:10.1371/journal.pone.0016880.g003
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previously investigated transcripts (Figure 4C & Table S2). Thirty-
four genes were overlapped between the 66 well-known genes and
49 genes with known splicing (Figure 4A & 4C). The exons of 15 of
the 34 genes were consistent with previous reported variants
(Table 3). Of the 15 genes, distinct functions of the alternative
isoforms in each gene were confirmed in 9 genes, including Gnao1
(Table 3). These might mediate neural events as a result of
alternative splicing. For instance, results of semiquantitative RT-
PCR and the SI value of Gnao1 showed that the Gnao1 B isoform
(189 nt) changed to the A isoform (124 nt) in P19 neuronal cells
(Table 2 & 3). This result is consistent with a previous report
showing that GNAO1 A isoform, but not the B isoform, is
required for the light response of retinal bipolar cells [30].
Among the 49 genes with known splicing, 15 genes overlapped
with 85 functional genes (Figure 4C). In this study, only the
splicing of the Abi2 gene in these 15 genes was analyzed by RT-
PCR (Table 2). Although a detailed expression analysis of splicing
has not been reported, the RT-PCR and SI results indicated that
the skipping isoform (149 nt) of Abi2 changed to an inclusion
isoform (329 nt) during the neuronal differentiation of P19 cells
(Table2). Interestingly, one previous study has reported a neural
function of Abi2 gene, showing that Abi2 is involved in ‘memory’
and ‘learning’ [31]. To test whether Abi2 splicing is related to this
higher brain function, alternative splicing was studied by brain
dissection, which revealed that the relative amount of the inclusion
isoform was increased in the frontal cortex compared with other
tissues (Figure S3). This preliminary result implies that the neural
splicing regulation of Abi2 is quite important for higher brain
functions.
Discussion
One important aspect of Exon Array projects in wet
laboratories is that the extracted candidates primarily consist of
actual alternative exons validated by RT-PCR. However, there
have only been a small number of projects in which the DAS
exons were efficiently extracted and validated by RT-PCR [12]. In
the present study, 87% of the 262 DAS exons were found to
change in the neuronal stage of P19 cells by semiquantitative RT-
PCR (Table 2). This score indicates that the filtering conditions
used efficiently extracted DAS exons from signals using Exon
Arrays. Another important aspect in Exon Array projects is the
ease of modifying the filtering conditions. To obtain more reliable
DAS exons, the threshold of the ABS_SId7 values in the sixth
procedure in Table 1 should be increased (e.g., from $1.35 to
$3.0). A higher ABS_SI value likely indicates a remarkable
change of alternative splicing in the RT-PCR experiments
(Table 2). Probesets with high ABS_SId7 values indicated
alternative exons in a ratio of approximately 40,50% in the
UCSC blat search (Figure 1B). There are probably many
alternative splicings in DAS exons with high ABS_SI values.
Indeed, these exons can be efficiently validated by RT-PCR in a
neural-specific manner.
Although the ABS_SId7 threshold can be variable, we think that
a threshold of ABS_SId7 $1.35 in the sixth procedure of Table 1 is
appropriate. According to the approximation curve, the percent-
age of predicted alternative exons decreased in the area of high
ABS_SId7 values. The percentage of predicted nonalternative
exons plateaued at an ABS_SId7 value of approximately 1.35
(Figure 1B). This is because the potential DAS exons accumulated
at an ABS_SId7 of $1.35. The inflection point between decreasing
range and a plateau state (e.g., in in Figure 1B) is probably suitable
for use as the ABS_SI threshold. It is also preferable to use
accessible software like the Expression Console and Excel. Open
access homology search tools such as NCBI BLAST or UCSC blat
are useful in the prediction of alternative exons, and reduce the
expense of the Exon Array analysis. The extraction method
Figure 4. Pathway analysis and text-mining. (A) A Flow chart of
informatics analyses at the gene-level (left) and exon-level (right).
PathwayStudioH was used on 236 DAS genes. The functions of 85 genes
were not reported in multiple studies, and these were categorized as
unknown genes (*). Sixty-six genes were reported in studies on the
functions in neural cells or organs, and were categorized as well-known
genes. Another 85 genes were categorized as functional genes. The
approach for the 85 functional genes is described below. Among the
236 DAS genes, 49 were reported in articles on ‘splicing variant’ or
‘isoform’. Thirty-four genes overlapped with the 66 well-known genes.
Further confirmation was performed (Table 3). (B) Number of cell
processes in pathway analysis of DEX-up and/or DEX-down genes (see
Figure 3C). Orange, blue, and yellow indicate the number of biological
processes from DEX-up genes, DEX-down genes, or both, respectively.
Since DEX-up genes are primarily important for neural-events and DEX-
down genes are not (see Figure 3), it is predicted that 189 biological
processes take place in the neural differentiation. Forty-seven of the 85
functional DAS genes from the remaining 170 genes, whose functions
matched with the 189 specific biological processes of the DEX-up
group, were extracted. (C) Number of genes in Figure 4A. Upper box
shows 66 well-known (purple), 85 unknown (*), and 85 functional
genes. Among the 85 functional genes, 38 genes were not linked
(green) and 47 genes were linked with the 189 processes and were
categorized as potential genes for neural regulation (orange). Among
the 236 DAS genes, 49 genes (red) were found in articles concerning
‘splicing variant’ or ‘isoform’ (lower box) and 34 genes were found in
articles of neural functions.
doi:10.1371/journal.pone.0016880.g004
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DAS exons in wet laboratories, because it is useful in projects that
employ a small number of samples and promotes the compre-
hensive analyses of alternative splicing events.
We detected novel splicing patterns in 7 alternative splicing
events among 30 randomly selected exons from 262 DAS exons
(Figure 2 & Table 2). Therefore, there are still many undetermined
alternative splicing events. It is possible that probesets that were
removed in the prediction of alternative splicing (Table 1; eighth
procedure) also contain novel alternative exons. The latest
software or the scoring of exons using exonic splicing enhancer
(ESE) and exonic splicing silencer (ESS) may accurately predict
DAS exons [32,33]. Such scoring is especially important for
aberrant splicing events, which are frequently observed in cancer
cells [34].
In addition to these sequence data, the results of informatics
analyses showed that only 49 of the 236 DAS genes have been
reported in previous articles of ‘alternative splicing variants’
(Figure 4). Although this informatics analysis is a new trial to
identify exon-level annotations, it is likely that insufficient
researches has been performed on splicing isoforms. Moreover,
there is no assembled database that shows the relationship between
a function and each distinct splicing isoform, even though
databases for functional analysis are substantial in annotations of
genes and proteins. Expression profiles containing alternative
splicings are accumulating in databases. Therefore, exon-level
informatics analyses will only increase in importance.
Forty-nine of the DAS genes were splicing ‘isoform’ or ‘variant’.
Of these, 34 genes had well-studied functions in neural cells or
organs. Nine of the 34 genes have a reported distinct function for
their alternative isoforms (Table 3). In particular, one Gnao1
isoform, GNAO1 A, is required for light response [30]. Gnao1 B
(189 nt) was a major product in undifferentiated P19 cells and
changed to Gnao1 A (124 nt) in neural differentiated P19 cells
(Table 2 & Figure S1). Among adult mouse tissues, Gnao1 A was
abundant in brain or brain dissections (Figure S1 and S3).
Therefore, it seems that the splicing regulation of Gnao1 is
primarily involved in neural differentiation. Although Abi2 is one
of the 49 genes with known splicings, it was categorized with the
85 functional genes. Distinct functions for the Abi2 isoforms are
unknown. The skipping isoform (149 nt) of Abi2 was replaced with
the inclusion isoform (329 nt) in neuronal differentiated P19 cells
(Table2 & Figure S1), and this isoform was largely detected in the
frontal cortex of the adult mouse (Figure S1 & S3). Alternative
splicing regulation of Abi2 may be important for higher brain
functions, based on the present results and the previous finding
that Abi2 mediates ‘memory’ and ‘learning’ [31].
Along with Abi2, the 85 functional genes may be the most
important group to investigate alternative splicings, since they are
substantially unknown in neural cells or organs. To extract
potentially important DAS genes from the 85 functional genes,
both alternative splicings and gene expressions were examined.
Informatics analyses showed that many DAS genes and DEX-up
genes were involved in neural-related events (Figure 3C). Based on
the GO biological process terms, we assumed that the DEX-up
genes, but not the DEX-down genes, were responsible for events in
P19 neuronal cells (Figure 3C). The protein expression levels of the
DEX-down genes are probably reduced in P19 neuronal cells.
Reductions or disruptions of DEX-down proteins may prevent
them from functioning in the differentiated cells.
Some of the DAS genes likely directly or indirectly affected on
expressions of the DEX-up genes, and some of the DEX-up genes
likely affected on alternative splicings of DAS genes [10].
Therefore, from the pathway analysis, the links between 189 cell
processes of DEX-up genes and 85 functional genes out of 236
DAS genes were examined (Figure 4A). Eleven of the 47
presumably important DAS genes mediated the G1/S transition
in the neuronal differentiation of P19 cells (Figure 5). The
regulations of alternative splicing in the 11 DAS genes may play
important roles in the cell cycle regulation. This informatics result
is very reasonable, since cell proliferation and cell differentiation
are highly associated. Some alternative events have been also
investigated, but there are still unknown frontiers in alternative
splicing research (Table 3).
Figure 5. Pathway analysis of 47 DAS genes. PathwayStudioH was used to find linkages between the 85 functional genes and 189 biological
processes (see Figure 4A). Forty-seven DAS genes and their linked to biological processes are shown. Cell cycle–related functions were found (orange
& red), especially those relate to the G1 and/or S phase (red).
doi:10.1371/journal.pone.0016880.g005
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‘‘Exon’’ Reported regulations Position indicated by Isoform name Distinct function of the isoform
Protein Probeset ID in neural cells or organs ‘‘Probeset’’-‘‘Article’’ with/without ‘‘Exon’’ SId7 Function PMID
DTNA 5566371 regulation of synapse, etc same a-dystrobrevin-2/1 1.56 viral life cycle 12475945
EPB4.1 5594543 cytoskeleton assembly, etc same Epb 4.1 variant1/2 2.70 cytoskeleton
assembly
9092575
5012146 same Epb 4.1 variant1/3 1.50 9092575
GNAO1 4489479 neurotransmitter uptake same Gnao1B/A 21.62 neurotransmitter
uptake
12077185
GPHN 4505349 synaptic transmission, etc same Gphn2,4,6/2,6 21.74 Mo-cofactor
synthesis
18411266
KITL 5091217 neurogenesis, etc same SCF248/220 1.47 proteolysis 7507105
MTAP2 5123064 cytoskeleton assembly same Map2s/c 13.22 neuclear
localization
10383434
5161361 neurite outgrowth, etc. same HMW/LMW map2 23.24 10383434
NFASC 5439373 cell contact, same NF186/155 2.63 neurite
outgrowth
16314110
4436418 cell adhesion same 2.11 16314110
PITX2 4556486 morphogenesis same Pitx2c/a 21.42 morphogenesis 10662647
THRA 4582355 Glucose metabolism, same c-erbA a1/2 21.79 DNA binding, etc 2901090
4705058 neurogenesis, etc. same c-erbA a2/3 (&1) 1.44 2901090
ABCC5 5507375 relaxation same ABCC5 SV1, 2, 3/ 2.62 not found N/A
CSF1 5305033 microglia activation, etc same Csf1 variant3/1 22.75
CUGBP2 4579194 RNA splicing, etc same Napor-3/Etr-3 21.59
NRCAM 5034147 axon guidance, etc. same Nrcam variant1/2 11.80
SYT7 5121401 vesicle exocytosis, same Syt7 variant3 (g)/1 2.58
4667795 endocytosis, etc same Syt7 variant2/1 2.60
EPB4.1L3 5517310 organogenesis same not determined 2.76
4866829 same 2.04
APLP2 5477899 axon cargo transport, etc different Aplp2 variant2/1 2.04 chondloitin
modification
17371289
GAS7 4941178 cell growth, etc. different Gas7a/b 2.50 neurite outgrowth 15948147
RBM9 5479607 RNA splicing different Fox-2f/a 2.04 RNA splicing 17715393
TCF4 4886763 neuron differentiation different Mitf-2a/b 1.85 transcription 8631961
CACNA1B 4683815 synaptic transmission, etc different Cacna1b variant1/2 21.35 not found N/A
CLTA 4399984 neurotransmitter secretion different LCa variant2 (&3)/1 3.05
DLG3 5344442 synaptogenesis different Dlg3 variant1/2 5.39
TSC2 5151584 S phase, etc. different Tsc2 isoform 5/4 1.87
EGFR 5316652 axonogenesis, etc. different Egfr variant2 (&4)/1 2.96
BCL2L11 5411420 neuronal death, etc different undetermined 2.26 N/A
ENPP3 4509455 cell differentiation different 3.16
4522439 different 2.38
FRAP1 4375053 synaptic plasticity, etc different 1.78
MBNL1 4357388 reflex different 22.16
SFRS8 4922980 RNA splicing different 1.78
SPP1 5403558 synaptic plasticity, etc different 22.07
APBB1 5391818 RNA splicing different 21.47
NDRG4 4329704 cell proliferation, etc different 21.54
PDE7A 5142491 memory different 2.74
PIM2 4775974 cell proliferation different 3.42
Curation confirmed that 34 DAS genes (40 DAS exons) were reported to be variants or isoforms (see Figure 4A). The probeset ID sequences of 40 DAS exons and
previous literature on the variants of these genes were compared to confirm whether the sequence and the variants indicated the same isoforms. The literature was also
searched for the distinct functions of the isoforms.
doi:10.1371/journal.pone.0016880.t003
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alternatively spliced transcripts. These profiles included key factors
and their potential targets in the transcriptional and alternative
splicing networks. Among the DEX-up and DAS genes, we
observed 20 and 14 RNA processing-related genes, respectively.
These genes may play key roles in neural splicing regulation. For
instance, RBM9 was included in both the DAS and DEX-up
groups. The splicing activity of the RBM9 isoform, which is
indicated by the DAS exon, is reduced compared to that of
another isoform [35]. This study also focused on the cell cycle-
related genes (Figure 5). SRp38/NSSR1, which we previously
detected during neuronal differentiation in P19 cells [22], is a
known splicing repressor via dephosphorylation in M-phase
specific manner [36]. Nucleophosmin (NPM) is another cell
cycle-dependent splicing regulator [37] that is phosphorylated
during the G1/S transition. These splicing regulators and their
potential targets may be very important in future studies clarifying
the alternative splicing networks involved in the neuronal
differentiation of P19 cells.
Supporting Information
Figure S1 Semiquantitative RT-PCR. (A) Schematic repre-
sentations of alternative splicing. Thirty of the 262 DAS exons
were randomly selected, and 25 alternative splicings are shown
above. The remaining splicings are shown in Figure 2. Boxes and
middle lines indicate exons and introns, respectively. Gray
indicates a possible alternative exon. Arrows indicate locations of
the primer annealing sites. Numbers indicate the length of PCR
products. The sequences of PCR products were confirmed by
sequencing analysis. Semiquantitative RT-PCR during P19 cell
differentiation (Day 0, 1, 4, 7, and 10) (B) and in adult mouse brain
and other tissues (C). b-Actin was used as a control. GluR1 was used
as a neural differentiation marker (B only). Schematic represen-
tations of PCR products are shown on the right side of the panels.
(TIF)
Figure S2 Graphical representations of semiquantitative
RT-PCR. Results of semiquantitative RT-PCR (see Figure 2A, 2B,
S1) followed by densitometric analysis are shown in the graphical
representation. The amount of each PCR product was divided by
total amount in each lane. Percentages are shown in the histogram.
Bars indicate the standard error. Numbers on the right side of the
graph indicate the length of PCR products. Numbers at the bottom
of the graph show the time course: Day 0 (undifferentiated stage),
Day 7 (neuronal stage), and Day 10 (early glial stage).
(TIF)
Figure S3 Alternative splicings in brain dissection.
Semiquantitative RT-PCR experiments were performed using
total RNAs of Skeletal muscle, brain, frontal cortex, hippocampus,
cerebellum, spinal code (left). Total RNAs of brain dissection are
commercially available (Takara). Gnao1 and Abi2, but not Kif21b,
are categorized among the 49 genes with known splicings. Distinct
functions of the Gnao1 isoforms, but not of the Abi2 isoforms, were
previously reported, but not Abi2. b-Actin was used as a control.
Schematic representations of alternative splicings are shown
(right). Boxes and middle lines indicate exons and introns,
respectively. Gray indicates a possible alternative exon. Arrows
indicate locations of the primer annealing sites. Numbers indicate
the length of PCR products.
(TIF)
Table S1 PCR primers. Primer sequences, annealing tem-
peratures, and PCR cycles are shown. In the case of $3 primers in
a DAS exon, multiplex PCR was performed.
(XLS)
Table S2 List of the 262 DAS exons.
(XLS)
Table S3 List of the 1,666 DEX-up genes.
(XLS)
Table S4 List of the 550 DEX-down genes.
(XLS)
Table S5 List of the 47 DAS genes and their cell
processes.
(XLS)
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